Investor Relations Captor Therapeutics ®
Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase
Current Report No. 3/2023
Date of preparation: 14 February 2023
Subject: Adoption of a resolution by the Company's Management Board on the issue of shares within the framework of a target share capital increase
Legal basis: Article 56(1)(2) of the Act on Public Offering - current and periodic information
The Management Board of Captor Therapeutics S.A., based in Wrocław (the "Company"), announces that on 14 February 2023, the Company's Management Board adopted a resolution on the issue of 11,292 series N ordinary bearer shares, within the limits of the Company's authorised capital, excluding, in full, the pre-emptive rights of the Company's existing shareholders.
The share issue is related to the implementation of a share-based incentive programme for employees and members of the Company's bodies. Enclosed the Company communicates the content of the adopted resolution.